Logo do repositório
 
Publicação

Effect of funding medications for nicotine dependence on tobacco control

2025-01-01Recensão Acesso aberto
Ver registo simples
dc.contributor.authorRábade-Castedo, Carlos
dc.contributor.authorMorais, António
dc.contributor.authorRavara, Sofía
dc.contributor.authorGranda-Orive, Jose Ignacio de
dc.contributor.authorBoléo-Tomé, Jose Pedro
dc.contributor.authorRiesco-Miranda, Juan Antonio
dc.contributor.authorPinedo, Angela Ramos
dc.contributor.authorMartinez, Eva de Higes
dc.contributor.authorMuñiz, Manuel Ángel Martínez
dc.contributor.authorPérez, Ruth Pitti
dc.contributor.authorFernández, Maribel Cristóbal
dc.contributor.authorJiménez-Ruiz, Carlos A.
dc.contributor.institutionComprehensive Health Research Centre (CHRC) - Pólo ENSP
dc.contributor.institutionCentro de Investigação em Saúde Pública (CISP/PHRC)
dc.contributor.institutionEscola Nacional de Saúde Pública (ENSP)
dc.contributor.pblElsevier Espana S.L.U
dc.date.accessioned2025-05-30T21:19:49Z
dc.date.available2025-05-30T21:19:49Z
dc.date.issued2025-01-01
dc.descriptionFunding Information: Smoking at the time of surgery is associated with postoperative complications. Quitting smoking before surgery is linked to fewer complications during the hospital stay. A Spanish study analyzed whether a smoking cessation intervention before surgery is economically worthwhile when funded by the National Health System. Smoking cessation increased by 21.7% with funding; the rate was 32.5% when funded versus10.7% without funding, producing 9611 extra quitters. The cost per averted smoker was \u20AC1753 with a benefit of \u20AC503, achieving a net economic benefit of \u20AC4.8 million per year. The return on investment was 28.7% annually, equivalent to \u20AC1.29 per \u20AC1 of investment. 43 Publisher Copyright: © 2025 Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
dc.description.abstractPharmacological treatments for smoking associated with psychological counseling triple the chances of quitting. However, the accessibility of these drugs is limited by their financial cost. With this review we aim to demonstrate the effect of partial or full funding in terms of efficacy, effectiveness, cost-effectiveness and quality of life. We conducted a literature search for articles related to the issues mentioned above: analysis of the efficacy, effectiveness and cost-effectiveness of pharmacological treatments for nicotine dependence and the effect of their funding. It is shown that the funding of pharmacological treatment can increase the efficacy and effectiveness of smoking cessation interventions. Such funding increases motivation to make a quit attempt. In addition, these strategies can increase self-efficacy, generate social influence and change attitudes toward quitting. Although the funding of pharmacological treatment benefits all smokers, there are certain populations of smokers who are more sensitive to funding strategies such as social groups with lower incomes and lower educational attainment. These funding strategies for smoking cessation interventions have been shown to improve the health and quality of life of the population, as well as the economy, while reducing tobacco use.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent531170
dc.identifier.doi10.1016/j.opresp.2025.100410
dc.identifier.issn2659-6636
dc.identifier.otherPURE: 117167287
dc.identifier.otherPURE UUID: 11f57ee6-05bd-408a-a9eb-e0cd861608f4
dc.identifier.otherScopus: 85219071967
dc.identifier.otherPubMed: 40104011
dc.identifier.otherPubMedCentral: PMC11915161
dc.identifier.urihttp://hdl.handle.net/10362/183668
dc.identifier.urlhttps://www.scopus.com/pages/publications/85219071967
dc.language.isoeng
dc.peerreviewedyes
dc.subjectEfficacy
dc.subjectFinancing
dc.subjectPharmacological treatment
dc.subjectSmoking
dc.subjectPulmonary and Respiratory Medicine
dc.subjectSDG 3 - Good Health and Well-being
dc.titleEffect of funding medications for nicotine dependence on tobacco controlen
dc.title.subtitlea narrative reviewen
dc.typereview
degois.publication.issue1
degois.publication.titleOpen Respiratory Archives
degois.publication.volume7
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
RabadeCastedo_2025_Open_Resp_Archives_7_100410.pdf
Tamanho:
518.72 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

Home collection (ENSP)